Biochemical and cellular mechanisms of mammalian CDK inhibitors: A few unresolved issues

Xin-Hai Pei, Yue Xiong

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

p21 and p16, first identified as two small molecular weight proteins in CDK and cyclin immunocomplexes, represent two distinct families constituting a total of seven CDK inhibitors in mammalian cells. The physiological functions of these genes are believed to be broadly involved in connecting various cellular pathways to cell cycle control. Extensive studies over the past 10 years have led to a fairly clear understanding of their biochemical and cellular mechanisms and have also left some unresolved and controversial issues.

Original languageEnglish
Pages (from-to)2787-2795
Number of pages9
JournalOncogene
Volume24
Issue number17
DOIs
StatePublished - Apr 18 2005
Externally publishedYes

Fingerprint

Cyclins
Cell Cycle Checkpoints
Molecular Weight
Genes
Proteins

Keywords

  • CDK
  • CDK inhibitor
  • Cyclin
  • p16
  • p21
  • PCNA

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Biochemical and cellular mechanisms of mammalian CDK inhibitors : A few unresolved issues. / Pei, Xin-Hai; Xiong, Yue.

In: Oncogene, Vol. 24, No. 17, 18.04.2005, p. 2787-2795.

Research output: Contribution to journalArticle

@article{b007a7113a674e749930e5260053220c,
title = "Biochemical and cellular mechanisms of mammalian CDK inhibitors: A few unresolved issues",
abstract = "p21 and p16, first identified as two small molecular weight proteins in CDK and cyclin immunocomplexes, represent two distinct families constituting a total of seven CDK inhibitors in mammalian cells. The physiological functions of these genes are believed to be broadly involved in connecting various cellular pathways to cell cycle control. Extensive studies over the past 10 years have led to a fairly clear understanding of their biochemical and cellular mechanisms and have also left some unresolved and controversial issues.",
keywords = "CDK, CDK inhibitor, Cyclin, p16, p21, PCNA",
author = "Xin-Hai Pei and Yue Xiong",
year = "2005",
month = "4",
day = "18",
doi = "10.1038/sj.onc.1208611",
language = "English",
volume = "24",
pages = "2787--2795",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "17",

}

TY - JOUR

T1 - Biochemical and cellular mechanisms of mammalian CDK inhibitors

T2 - A few unresolved issues

AU - Pei, Xin-Hai

AU - Xiong, Yue

PY - 2005/4/18

Y1 - 2005/4/18

N2 - p21 and p16, first identified as two small molecular weight proteins in CDK and cyclin immunocomplexes, represent two distinct families constituting a total of seven CDK inhibitors in mammalian cells. The physiological functions of these genes are believed to be broadly involved in connecting various cellular pathways to cell cycle control. Extensive studies over the past 10 years have led to a fairly clear understanding of their biochemical and cellular mechanisms and have also left some unresolved and controversial issues.

AB - p21 and p16, first identified as two small molecular weight proteins in CDK and cyclin immunocomplexes, represent two distinct families constituting a total of seven CDK inhibitors in mammalian cells. The physiological functions of these genes are believed to be broadly involved in connecting various cellular pathways to cell cycle control. Extensive studies over the past 10 years have led to a fairly clear understanding of their biochemical and cellular mechanisms and have also left some unresolved and controversial issues.

KW - CDK

KW - CDK inhibitor

KW - Cyclin

KW - p16

KW - p21

KW - PCNA

UR - http://www.scopus.com/inward/record.url?scp=18344369616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18344369616&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208611

DO - 10.1038/sj.onc.1208611

M3 - Article

C2 - 15838515

AN - SCOPUS:18344369616

VL - 24

SP - 2787

EP - 2795

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 17

ER -